Introduction
Brucellosis is an endemic zoonosis in Syria, affecting large numbers of animals and an increasing number of cases in humans. It is considered as the most important public health problem due to its high morbidity. The severity of disease in humans correlates with its severity in animals, especially in domestic ruminants. 1 Furthermore, brucellosis continues to have great economic importance considering decreased milk production, infertility, abortions, and weight loss. 2 Brucella melitensis remains the major cause of human disease worldwide, followed by B. abortus and B. suis. Rare cases of human infections caused by B. canis and pathogenic brucella of marine mammals have also been reported. 3, 4 Despite existing brucellosis worldwide, it is considered as an endemic disease in Mediterranean basin, Middle East, Western Asia, Africa, and Latin America. 5 In spite of the development of new antibiotics as well as new treatment strategies, only few modifications have been applied to brucellosis treatment since its introduction half a century ago. [6] [7] [8] Treatment of human brucellosis is still based on the World Health Organization (WHO) recommendations applied in 1986, 9 suggesting the use of doxycycline, 100 mg twice daily for six weeks combined with either rifampicin, 600-900 mg daily for six weeks, or streptomycin, 1 g daily for 2-3 weeks. In addition, rifampicin monotherapy is the only viable option for treatment during pregnancy. Whereas a combined therapy with rifampicin and trimethoprim-sulfomethoxazole is recommended for children. 10, 11 Some disease complications, such as: endocarditis, meningitis, and spondylitis, were treated with triple-antibiotic combinations. 12, 13 Quinolones are an alternative to conventional treatment agents, [14] [15] [16] and clinically similar results were obtained with rifampicin-ofloxacin and rifampicin-doxycycline combinations. 17 However, the treatment of brucellosis is still problematic due to emerging resistance, which yield to high rates of treatment failure and relapses. Thus, it is necessary to develop new antibacterial drugs for treatment of brucellosis. 18 The antimicrobial activity of medicinal plant extracts justifies them to be used in many fields such as food industry, pharmacy and medicine. Medicinal plants have always been sources for discovery of new drugs. Plants, easily protect themselves against various enemies such as insects and microorganisms by synthesizing special substances. 19 Moreover, they maintain their normal growth and development by producing secondary antimicrobial metabolites. 20 Brillantaisia lamium extract is found to be of value against Staphylococcus aureus, Enterococcus faecalis, Candida tropicalis and Cryptococcus neoformans. 21 Whereas, Crimum pupurascens herb extracts and its components showed antimicrobial activity against Salmonella paratyphi A and B. 22 In addition, a strong anti brucella abortus A77 activity of Satureja hortensis essential oil has already been reported. 23 Lamiaceae family main components, thymol and carvacrol, interfere with cellular metabolism after penetrating into the cell. 24 Low concentrations of Prunus mahaleb seeds ethanolic extract showed a good efficacy against B. melitensis. 25 Furthermore, the lowest concentration of ethanolic and methanolic extracts of Oliveria decumbens and Vitex pseudo-negundo found to have antibacterial activity against tetracyclineresistant B. melitensis. 26, 27 In addition, almost all concentrations of Teucrium polium ethanolic extract, a member of the Lamiaceae family, were found to be effective against B. melitensis. 27 Rosmarinus officinalis L., Origanum syriacum, Thymus syriacus, Salvia palaestina Benth, Mentha piperia and Lavandula stoechas L. are traditional medicinal plants used in Syria for many purposes, particularly for respiratory and gastrointestinal disorders. The aim of this study was to evaluate in vitro antibacterial activity of essential oils of the above-mentioned plants against tetracyclineresistant B. melitensis isolates.
Materials and Methods

Microorganisms and Growth Conditions
In this prospective study, 89 brucella species were isolated from bovine and ovine milk from different Syrian provinces between 2004 and 2007.
Bacteria were isolated from milk cultures at the Immunology and Microbiology Laboratory, atomic energy commission of syria (AECS). 28 Brucella was grown under optimal conditions in 2YT agar (Difco, BD, USA), containing peptone 10 g, sodium chloride 5 g, meat extract 5 g, agar 20 g, and distilled water 1 liter, and incubated at 37°C water bath (Grant water; Cambridge, UK.) to secure sufficient cell density. The growth of contaminating microorganisms was inhibited by supplementing the growth medium with cycloheximide 100 mg, bacitracin 25000 units, polymyxin B sulphate 5000 units, vancomycin 20 mg, nalidixic acid 5 mg, and nystatin 100000 units (Oxoid, UK). 28 The solid selective media were then prepared by melting the basal medium, cooling to 56°C in a water bath, adding appropriate amounts of stock solutions of the antibiotics and 5% horse serum (PAN-Biotech, Gmbh, Germany). The biotyping of the bacteria was done by CO 2 requirement, H 2 S production, urease and oxidase positivity, growth in the presence of dyes (thionine and basic fuchsine), and reaction with monospecific anti-A and anti-M sera (Arcomex, Jordan). 29 Strains identified as B. melitensis or B. abortus were stored in 2YT medium at -20°C. Only 16 isolates of B. melitensis resistant to tetracycline by susceptibility test were used in the present study.
Plant samples Collection
The 
Essential Oil Extraction
Extraction of essential oils was carried out using water steam distillation device (Clevengertype apparatus) according to the European Pharmacopoeia method. 30 The device was attached to condenser and cold water recycler (Hydrodistillation technique). Distilled water was added (1:10 v/v) to each sample, and distilled for 2 h. The supernatant contained essential oil which was dehydrated by filtering through anhydrous Na 2 SO 4. The essential oil thus prepared was collected in airtight vials and stored in refrigerator.
Antibacterial Susceptibility Assay
The test isolates was grown in Muller-Hinton Broth (MHB, Merck) medium at 37°C for 22 h. The bacterial number in the final inoculum was adjusted to 10 6 CFU/ml. A bacterial lawn was prepared by pouring 0.1 ml of bacterial suspension onto each plate of Muller-Hinton Agar medium (MHA, Merck), spread by a sterile cotton swab, and allowed to remain in contact for 1 min. 5% concentration of each essential oil were prepared in order to impregnate the paper discs. The sterile filter paper discs containing tested essential oils (6-mm diameter) were then placed on the bacterial lawn. The Petri dishes were subsequently incubated at 37°C for 24 h and the inhibition zone around each disc was measured in mm. As positive controls, discs (Difco, BD, USA) containing tetracycline 30 µg, ciprofloxacin 5 µg, levofloxacin 5 µg, ofloxacin 5 µg and doxycycline 30 µg were used.
Antibiotics MIC Determination
Microdilution broth method in 96 microwell plates (TPP, Switzerland) was used to estimate the antibiotic's susceptibility. Two-fold dilutions of antibiotics in brucella broth (acumedia, Michigan, USA) prepared in wells were inoculated with 10 6 CFU of bacteria with final volume of 0.2 ml in each micro-well plate, and incubated for 48 hours at 37°C. The MIC was expressed as the lowest concentration that completely inhibited visual growth. Furthermore, the lowest concentration inhibiting 90% of visual growth was considered as MIC 90 . MIC testing was performed according to the recommendations of the clinical laboratory standards institute. 31 The concentrations assayed for each antibiotic ranged from 0.064 to 128 μg/ ml. The absorbance was determined at 590 nm (Thermo-lab Systems Reader, Finland). All tests were performed in triplicate and then averaged. The antibiotics investigated included levofloxacin, ofloxacin, sparfloxacin, ciprofloxacin and doxycycline, along with a blank test containing no antibiotics.
Determination of MIC of Essential Oils
Microdilution broth susceptibility assay was performed using three replicates of each serial dilutions of essential oil prepared in brucella ® broth medium in 96-well microtiter plates. 32 The concentrations of each essential oil in serial dilutions ranged from 0.75 to 100 µl/ml. The content of each well was supplemented with 100 μl of freshly grown bacterial culture containing 10 6 CFU/ml in brucella broth. The assay included positive control without essential oil and negative control lacking bacteria under the same conditions. The plate was incubated with shaking for 24 h at 37°C. The MIC was expressed as the lowest concentration that completely inhibited visual growth. Moreover, MIC 90 was the lowest concentration that inhibited 90% of visual growth with absorbance at 590 nm.
Essential Oil-Antibiotic Combination Effect
Two B. melitensis isolates were employed to evaluate the additive effects of various concentrations of T. syriacus essential oil on the MIC of levofloxacin. MIC was determined as described above. Two dilutions containing 3.125 and 6.250 µl/ml, of T. syriacus essential oil were then added to the 96-well microtiter plates to determine the MIC. The lowest concentration (table 3) . In addition, table 4 revealed that T. syriacus essential oil reduced the MIC 90 level of levofloxacin from 32 to 4 µg/ml in both isolates studied, whereas, it decreased the MIC 50 level from 0.125 to 0.064 µg/ml in only one isolate.
Discussion
Human brucellosis therapy requires antibiotics which are capable of penetrating the macrophages and act efficiently under acidic conditions. Antimicrobial drug resistant strains emerge frequently, 33 and lead 1  22  18  27  22  29  22  2  23  16  6  10  9  9  3  25  18  15  26  27  20  4  22  17  6  25  21  12  5  20  15  8  27  15  23  6  22  12  15  27  26  10  7  23  17  6  13  20  8  8  22  19  16  14  9  14  9  22  18  7  21  27  22  10  23  18  18  25  26  19  11  23  12  22  26  26  26  12  22  13  7  23  19  16  13  22  18  17  26  22  9  14  23  16  6  15  20  15  15  25  16  12  31  16  20  16  20  19  9  30  18 12 34 reported that the extracts of many plants worldwide, were suitable for treating bacterial, fungal or viral infections. Brul and co-worker highlighted the mechanisms of antimicrobial effects in certain plants. 35 In addition, phenolic and aromatic compounds of medicinal plants seems to possess an essential antibacterial role. 36 The growth of B. melitensis is affected by thymol and carvacrol. These are major phenolic components of thymus oil with prominent outer membrane disintegration activity that increased the permeability to ATP through cytoplasmic membrane. 37, 38 In this context, several in vitro experiments showed a wide spectrum of antimicrobial activity in thymus oil and its phenolic components. 39 Most of the plants used in this study are used in traditional medicine across Syria to cure respiratory and gastrointestinal disorders. Thus, these plants could be explored to evaluate their efficacy against. As demonstrated in table 2, the efficacy of antimicrobial activities of essential oil of tested plants was determined, quantitively, by measuring the diameter of inhibition zones around the discs. Only O. syriacum and T. syriacus extracts inhibited the growth of B. melitensis. The MIC 50 values of O. syriacum and T. syriacus aqueous extracts were 3.125 µl/ml and 6.25 µl/ml, respectively. Reuben et al. 40 found that the MIC and MBC often had comparable or close values, concluding that the essential oils of O. syriacum and T. syriacus possessed bactericidal effect on B. melitensis. Darabpour et al. found that the methanolic extract of Peganum harmala L seed exhibited a broad antibacterial activity against B. melitensis even at lowest concentration (50 mg/ ml). 41 Shapouri and Rahnema reported the MIC of aqueous hops extract for B. abortus 544 and B. melitensis 16M, as 0.625 mg/ml, whereas that of acetonic and ethanolic extracts being 0.05 mg/ml. 42 Motamedi and his colleagues studied the effect of plant extract-antibiotic combination against B. melitensis, and observed a synergitistic activity in the combination of Oliveria decumbens extracts and doxycycline. In our in vitro study of T. syriacus aqueous extract of essential oil, a good additive activity against two B. melitensis isolates was demonstrated when it was used in combination with levofloxacin.
Conclusion
Our study showed that O. syriacum and T. syriacus essential oils were most effective against B. melitensis. This could provide a potential source of new antibacterial agents which is worthy of clinical trials. In addition, doxycycline, levofloxacin and ofloxacin were the most effective antibiotics. Moreover, levofloxacin and Thymus syriacus essential oil combination was more effective than either antibiotic or the essential oil alone.
Further and more specific studies, in vivo, are recommended to determine the efficacy of these essential oils in the treatment of brucellosis infections.
